Protagonist Logo. Click to navigate to a home page

Digestive Diseases Week® (DDW) Conference

June 2, 2018 12:00 PM ET

Location: Walter E. Washington Convention Center in Washington, D.C. United States

Presentation Title: Oral delivery of peptides with dual mu/delta opioid receptor agonist activities are superior to eluxadoline in preclinical models of IBS-D
Session: 
Diarrhea and Irritable Bowel Syndrome - New Advances
Presenting author: 
Larry Mattheakis, Vice President of Biology, Protagonist Therapeutics, Inc.

Share by: